ABSTRACT
Based on the previous characteristics and considering the importance of peptide dendrimers, the main objective of this review was to explore their different biomedical applications in the last 10 years. In this context, the design of new drug delivery systems, gene delivery, and their activity as therapeutic agent, will be emphasized. In addition, other biological uses will be presented and briefly discussed herein.
Drug delivery
Drug delivery has been a challenge towards improving bioavailability and, specially, increasing selectivity, which lowers toxicity. 14 Drugs can be bound to the dendrimers, either leading to prodrugs or targeted drugs 15 or be encapsulated in these nanostructures, through weak interactions. 16 It is worth noting that several targeting strategies based on the fact that carbohydrates have the ability to target active sites, have been explored. Mannose, for example, can be recognized by macrophages and also neutralize cationic charges on dendrimer surface, which increases toxicity 17 Other cells, as hepatocytes, show receptors sensitive to galactose interaction, allowing liver selectivity for some drugs.
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Encapsulated-dendrimers have attracted interest in recent years due to their unique properties, such as well-defined size, globular shape, and internal empty space, allowing encapsulate drugs through electrostatic, complex formation, van der Waals forces and H-bonding interactions. Their properties permit increasing drug/bioactive compound water solubility as well. 19 Poly(amidoamine) (PAMAM) has been employed to encapsulate poorly soluble bioactive compounds, increasing solubility successfully, enhancing their activity. 20 Many approaches have been used to achieve drug delivery. Self-assembled nanocarrier is a recent trend in its potential design. There are interesting examples in the literature concerning this mechanism of drug delivery. 6, 21 Verma and coworkers D r a f t 4 Transdermal delivery has also attracted interest in the academic community and there are some peptide nanocarriers designed for this application. Conjugation with iontophoresis was described by Mutaliki and colleagues 23 (2013) (Figure 1 ), who synthesized peptide dendrimers, constituted of arginine and histidine, as terminal groups and composed of 4, 6 and 8 molecules of each amino acids. Their stability was tested in receptor solution on epidermis, dermis and skin, and showed that there was not noticeable degradation, with 98.9% stability in all these tests after 6 h at room temperature. In passive diffusion, dendrimers with higher molecular weight did not permeate across the skin. On the other hand, dendrimers with lower molecular weight permeated across the skin, with good stability profile. Iontophoresis increased significantly the permeation of all compounds, meaning that permeation is dependent on molecular weight rather than on the positive charges of the amino acids. The capacity of peptide dendrimers to cell-internalize has been a challenge to the delivery of some drugs, mainly in oncology. Although many therapeutic classes of drugs face delivery problems, most examples in literature are related to chemotherapeutic agents, especially to anticancer drugs. 26 The reason for increasing interest in this class of drugs and bioactive agents is, usually due to their high toxicity and low selectivity, which frequently leads to interruption of the treatment or death. Thus, proper and specific drug delivery systems would be of utmost importance and peptide dendrimers are able to achieve that purpose.
Examples of anticancer drug delivery systems and other drugs are as follows.
Anticancer drug delivery systems
New approaches to reduce toxicity and improve bioavailability are underway for cancer therapy like dendrimer nanoparticles used as a vehicle for drug delivery. Receptor-mediated endocytosis (RME) or the effect of enhanced permeability and retention (EPR) enzyme-responsive and pH-responsive strategies have also been applied towards toxicity decrease and selectivity enhanciment. 28, 29 In 2015, Oledzka and colleagues 30 designed macromolecular drug delivery systems containing poly-lysine dendrimers, surface groups composed of arginine-6-oligomer and amphiphilic copolymer poly(3-hydroxybutyrate (PHB)-poly(ethylene glycol) (PEG)-PHB, as core. In this context, they proposed a biodegradable poly-(Llysine) dendrimer presenting arginine as functionalized-end aiming at synthesizing a chemically polyvalent copolymer. This might be conjugated to drugs through covalent bonds and be further. Colchicine, which has not been used as a chemotherapeutic agent due to its cytotoxicity, 31 was one of the drugs tested.
Peptide dendrimers comprising amino acid combinations, as aspartate, histidine and serine, were conjugated to carbohydrates in their surface with antineoplastic drugs as delivery systems. Colchicine was conjugated to dendrimers and once it was coupled with glycopeptide dendrimers, it presented decrease of toxicity and increase of cellular uptake, when compared to free colchicine. Probably, the proteolysis is the mechanism responsible for the uptake and the intracellular drug release in cancer cells.
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Despite doxorubicin (DOX) being one of the most potent anticancer drug, its application is limited by toxicity, such as cardiotoxicity, which causes cardiomyopathies leading, in some circumstances, to death. 28, 32 This has been a great challenge to the use of this drug in cancer chemotherapy and, therefore, many dendrimer peptides have been strategically used as an alternative to overcome its high toxicity and low selectivity as well.
Heparin is a natural water-soluble polysaccharide, which belongs to glycosaminoglycan family and has been used as anticoagulant drug. In addition, it can inhibit tumor growth and metastasis through recognition among selectins, heparanases, and growth factors. Heparin was dendronized with poly(L-lysine) and conjugated by pH-sensitive bonds with DOX (dendronized heparin-DOX conjugate nanoparticles selfassembled) (Figure 2 ) for the treatment of breast cancer. Histological analysis after using drug-dendron conjugate did not indicate toxicity in comparison with free DOX, demonstrating high antitumor activity on breast cancer cell line (4T1), antiangiogenesis effects and induced apoptosis. According to the authors, the dendronized heparin-DOX conjugate may be a background for the design of biosafe nanoparticles and efficient drug delivery systems. The use of amphiphilic dendrimers able to self-assemble is also a new approach directed to selectivity in general and of DOX in particular. 3,34 mPEGylated peptide dendrimer-DOX has been designed to be an enzyme-responsive drug delivery vehicle.
This drug was attached to the dendrimer surface through an enzyme-responsive tetrapeptide Gly-Phe-Leu-Gly (GFLG), cathepsin B substrate (overexpressed in tumor cells)
as directing group, and a spacer. PEG was used to increase blood residency time and tumor accumulation. These derivatives ( Figure 3 ) were able to self-assemble into nanoparticles. Furthermore, in immune-histochemical and histological analysis, they showed high antitumor activity and induced apoptosis on breast tumor model, demonstrating better results than free DOX. According to the authors, mPEGylated peptide dendrimer-DOX conjugate-based nanoparticles may be a promising drug delivery system for breast cancer chemotherapy. 34 Li and colleagues 34 (2014) published a similar work using the same approach, the PEGylated dendron connected to GFLG coupled to DOX, generating the enzyme-sensitive amphiphilic conjugate self-assemble
into nanoparticles negatively charged. This delivery system could be cleaved in the lysosome after endocytosis, releasing the drug for cancer therapy. This drug conjugated demonstrated better antitumor activity in the assays in breast tumor cells than free DOX. In addition, the results of in vivo assays showed increased antitumor activity and biosafety compared to the free drug. These results pointed out the potential of peptides for designing drug delivery systems. Other compounds, such as platinum derivatives, have been used for a long time to achieve antineoplastic effect. 41 Despite the fact that oxaliplatin is a new generation drug to treat cancer, there are limitations to its use, such as neurotoxicity and inactivation due to its coordination with plasma proteins. 42 Among the different approaches, the pH-responsive bond has also been used to link the drug to the carrier. Although naproxen important adverse effects, it has the ability of inhibiting the development of bladder cancer. Moreover, it activates the caspase pathway, which induces apoptosis in breast cancer cells. In in vitro test, it can suppress cell migration and inhibit the synthesis of prostaglandin E-2 (PGE-2). Curcumin, a natural product extracted from the herb Curcuma longa, has therapeutic effects involving antiinflammatory, antioxidant and antitumor activities, especially against osteosarcoma, breast and colon cancer. When curcumin is combined with a naproxen prodrug, one can expect synergistic antitumor effects. Peptide dendrimers with good capacity to deliver drugs were earlier designed and synthesized, and those with glutamic or aspartic acids showed high selectivity to bone tissue. With these data, naproxen modified dendrimer with oligo-aspartic acid to encapsulate curcumin into micelles was developed to treat osteosarcoma. After the encapsulation, curcumin disperse with naproxen-dendrimer can rapidly release from the micelles during in vitro assays. Curcumin micelle showed greater cytotoxicity to cancer cells than free curcumin and naproxen-dendrimer alone, inducing more apoptosis through a mitochondrial pathway. Micelle encapsulation allowed the absorption of curcumin by the cancer cells more selectively. 48 A more complex peptide dendrimer was designed by Ma et al., in 2017. 49 It is known that arginine-lysine-glycine peptide (RGD) have high affinity to integrin αvβ3 (it is overexpressed in tumors cells) being a promising target. 50 Based on this tripeptide and on the TAT-peptide (GRKKRRQRRRPQ), which is derived from the transcription transactivator (TAT) of human immunodeficiency virus, a CPP, the authors tried to enhance drug uptake in tumors cells, conjugating it to RGD and PAMAM dendrimer.
The problem of CPP nonspecific internalization, was overcome by PEG addition. The D r a f t authors synthesized the conjugate RGB-TAT-PEG-PAMAM with methotrexate (MTX), a known anti-cancer drug, and, together with a probe (FITC), it was encapsulated. Flow cytometry showed that RGD-TAT-PAMAM-PEG-FITC (RTPPF) uptake was higher than RGD-PAMAM-PEG-FITC (RPPF). in αvβ3 overexpressing HepG2. In confocal microscopy the conjugates were accumulated in HepG2 cells and co-localized at cell nucleus. The difference between them was the fluorescence intensity, which was stronger in RTPPF than in RPPF. Despite the fact that both could suffer endocytosis, RTPPF had better internalization. MTX complexes were more slowly eliminated than MTX and had 2-fold higher maximum tolerated regimen values.
Delivery systems for other drugs
The carbohydrates interaction with specific cell receptors, such as macrophages and liver cells, is used as a selective strategy, as mentioned before.
The poly(L-lysine) dendrimer four generation with PEG as core, and conjugated with D-galactose, is one example of this approach. This dendrimer interacts with the asialo-glycoprotein receptor in the liver, which recognizes galactose. The glycopeptide dendrimer was used to encapsulate chloroquine phosphate (CQ). The results obtained in vitro and in vivo, compared with the galactose-uncoated peptide dendrimer, showed that the latter allowed a slower drug release rate than the former, besides half-reducing the drug hemolysis rate. There was also a 5-time reduction in the macrophage uptake of this dendrimer. Therefore, data evidenced that coated peptide dendrimers were the most effective towards antimalarial target to the liver. 51 Other glycoconjugated peptide dendrimers were designed by Bhadra et al.
(2006). 52 They synthesized coated PEG-lysine dendrimers (PEG-Lys-CSA) and uncoated (PEG-Lys) with chondroitin sulfate A, encapsulating chloroquine phosphate (CQ) in both carriers, suggesting that dendrimer matrix prolonged the drug releasing time. This could be associated with the increase in PEG molecular weight and in dendrimer generations. However, in CSA-coated dendrimers, the increased viscosity and lack of free periphery groups led to a compact structure. The latter was less hemolytic than CQ and PEG-Lys-CQ, which might have masked free groups and charges of drug molecules. In the coated dendrimer, the uptake by macrophages was less than that observed for CQ itself. In addition, that compound was nearly 50% less cytotoxic, having a safe increasing blood circulation time. Although both dendrimers had some of their pharmacokinetics parameters increased, PEG-Lys-CAS-CQ retarded D r a f t 15 the drug release in more than 12 hours. Due to the dendrimer circulation increase, CQ was more available in blood than in liver and spleen with PEG-Lys-CAS-CQ.
Musculoskeletal diseases, as osteoarthritis and osteoporosis, represent an important public health problem, arousing great interest in research and development of drug-delivery systems that can efficiently transport the drug to the bone. These kinds of systems are especially important once we know that the bones, unlike other parts of the body, have a layer of hydroxyapatite, and some drugs, such as tetracyclines and bisphosphonates, display a high affinity to this substance. Therefore, these substances could work as targeting groups to bone. 53 Giarolla and colleagues have designed peptide dendrimers Lys-Arg-based aiming at obtaining cleavage by cruzain, which is a promising target in the planning of new antichagasic compounds. Peptide dendrimers were designed with molecules potentially active in Chagas' Disease, having their main objective to achieve the release of the active compound directed in the protozoan.
54

Gene delivery
Gene therapy is one of the most studied treatment for human diseases such as cancer and diabetes, usually, resulting in the knockdown dysfunctional genes of or in the increase of genes expression. One of challenges concerning this treatment is the gene products delivery to the site of action. 55, 56 Despite being the greatest technique used for gene delivery, viral vectors still have some problems such as mutagenicity and immune reactions. Several nanocarriers, from liposomes to dendrimers, present the key characteristics for being an efficient gene delivery, which can prolong blood circulation time, almost without immune reaction, high cellular uptake and early endosomal scape. PEI, it has much less cytotoxicity due to fewer positive moieties. 56, 58 Another interesting study developed by Zarebkohan et al. (2015) about dendrimers was related to gene delivery to the brain 59 The authors used 4th generation PAMAM dendrimer functionalized with SRL (serine-arginine-leucine), which is relevant as gene delivery, aming at crossing the blood-brain barrier (BBB). Moreover, comparing with PAMAM-arg and PAMAM-DAN particle, the results showed better uptake to the brain.
PAMAM derivative compounds were also built with phenylalanine and plasmid DNA in their periphery as agents for gene delivery. One of the dendrimers showed to be an efficient transfection agent, better than the commercially available transfection reagent PEI (polyethylenimine) and other derivatives from the series. 
D r a f t
Peptide dendrimers can display activity per se, in diagnosis, to stimulate immune response, as vaccines.
Diagnostic, biosensor and nanodiagnostics
MAP (Multiple Antigen Peptides) dendrimers presented better specificity to some antibodies than linear peptides in ELISA tests. Moreover, it has been used in many immunoassays to identify antigen, such as HIV, malaria, BTV (blue tongue virus), infectious bronchitis and other pathogens 63 . MAP dendrimers may have more than one different epitopes in the serodiagnosis of hepatitis C virus. 64, 65 Additionally, those dendrimers, acting as biosensors, could be used as probes to detect bioorganic compounds. 64 
Immune response and vaccines
Peptide dendrimers can be used to detect antibodies or immune responses with good sensitivity, for instance, that from PPR (Peste des petits ruminant virus) virus. 64, 65 Roy and coworkers published the first paper regarding glycopeptide dendrimers, in 1993. 62 The researchers reported the synthesis of a peptide dendrimer composed of 
Enzymes
Peptide dendrimers can be applied as artificial enzymes, as esterase, for instance.
These dendrimers were designed employing proteinogenic R-amino acids with branches containing diamino acids, with molecular weights ranging from 3 to 5 kDa. They were synthesized by solid-phase methodology, purified and dimerized by disulfide bond using cysteine residues. Combinations of aspartate, histidine, and serine, amino acids usually present in esterases and lipases, were coupled.
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CONCLUDING REMARKS
The use of peptide dendrimers for their potential applications must be encouraged. Although peptide synthesizes well-developed, dendrimers, on the other hand, also deserve growing interest. The association of the former and the latter must be D r a f t stimulated since it can generate better alternatives in terms of efficacy, synergism and selectivity of action. In this review, the main application of peptide dendrimers was on drug delivery systems, especially in cancer, which continues to be a huge challenge for the therapeutics. Nanocarriers, derived from peptide dendrimers, can also be used as gene delivery systems, but this area deserves more improvement, taking into account its complexity. Exploring the activity per se of these compounds is another interesting possibility of findings, especially, antinfectious agents. Compounds to bypass the problem of resistance are urgently needed. In all those areas the versatility of the peptide dendrimers, especially considering the possibility of using pH-sensitive linkage, self-assembly forming micelles, and the conjugation with different molecular architectures, is a quality that has to be better scrutinized toward innovation. 
